KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Hims & Hers Health (HIMS) Cost of Revenue (2020 - 2025)

Hims & Hers Health's Cost of Revenue history spans 6 years, with the latest figure at $238.0 million for Q4 2025.

  • For Q4 2025, Cost of Revenue rose 254.2% year-over-year to $238.0 million; the TTM value through Dec 2025 reached $919.3 million, up 575.88%, while the annual FY2025 figure was $919.3 million, 203.02% up from the prior year.
  • Cost of Revenue for Q4 2025 was $238.0 million at Hims & Hers Health, down from $397.3 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $397.3 million in Q3 2025 and bottomed at -$154.4 million in Q4 2024.
  • The 5-year median for Cost of Revenue is $54.1 million (2024), against an average of $88.4 million.
  • The largest annual shift saw Cost of Revenue skyrocketed 737.39% in 2022 before it crashed 462.73% in 2024.
  • A 5-year view of Cost of Revenue shows it stood at $22.6 million in 2021, then skyrocketed by 737.39% to $189.3 million in 2022, then crashed by 77.51% to $42.6 million in 2023, then plummeted by 462.73% to -$154.4 million in 2024, then soared by 254.2% to $238.0 million in 2025.
  • Per Business Quant, the three most recent readings for HIMS's Cost of Revenue are $238.0 million (Q4 2025), $397.3 million (Q3 2025), and $128.6 million (Q2 2025).